Patent assignee · BE · COMPANY

argenx BV

28Patents
28Active
28Granted
51Portfolio score

Filing activity: Jul 2, 2009 → Dec 13, 2024 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8834882B2 Antibodies to CD70 Chemistry; Metallurgy 28 Active
US8524231B2 Antigen binding polypeptides Chemistry; Metallurgy 12 Active
US8444976B2 Antigen binding polypeptides Chemistry; Metallurgy 12 Active
US8637027B2 Anti c-Met antibodies Chemistry; Metallurgy 9 Active
US8835607B2 Humanized antibodies Chemistry; Metallurgy 8 Active
US9221918B2 Antigen binding polypeptides Chemistry; Metallurgy 5 Active
US9428580B2 Antigen binding polypeptides Chemistry; Metallurgy 5 Active
US11505585B2 FcRn antagonists and methods of use Chemistry; Metallurgy 4 Active
US11591388B2 Pharmaceutical formulations of FcRn inhibitors suitable for subcutaneous administration Chemistry; Metallurgy 4 Active
US12240875B2 Use of FCRN antagonists for treatment of generalized myasthenia gravis Chemistry; Metallurgy 2 Active
US11712468B2 CD70 combination therapy Human Necessities 2 Active
US12202900B2 Compositions and methods for treating immune thrombocytopenia Chemistry; Metallurgy 2 Active
US11530271B2 CD70 combination therapy Chemistry; Metallurgy 1 Active
US11434298B2 Antibodies to CD70 Chemistry; Metallurgy 1 Active
US11827701B2 IL-6 binding molecules Chemistry; Metallurgy 0 Active
US11479879B2 Triple vector for expressing antibody molecules in full therapeutic format Chemistry; Metallurgy 0 Active
US11261246B2 Anti-IL-22R antibodies Chemistry; Metallurgy 0 Active
US12060413B2 Method of preparing pH-dependent antibodies Physics 0 Active
US12180293B2 CD70 combination therapy Chemistry; Metallurgy 0 Active
US11591386B2 Antibodies to human complement C2B Chemistry; Metallurgy 0 Active
US12030949B2 Multispecific antibodies against IL-5 and IL-4R Chemistry; Metallurgy 0 Active
US12071486B2 Bispecific antigen binding construct Chemistry; Metallurgy 0 Active
US11708403B2 Antibodies to human complement factor C2B and methods of use Chemistry; Metallurgy 0 Active
US12403175B2 Methods for treating pemphigus disorders Chemistry; Metallurgy 0 Active
US11447544B2 Anti-IL-22R antibodies Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.